Blood glucose control using a mobile health application in Singapore, Philippines and Hong Kong: a retrospective real‐world data analysis

Documenti analoghi

• Effectiveness and safety of once‐weekly subcutaneous semaglutide versus other glucose‐lowering agents in real‐world patients with type 2 diabetes: A retrospective, observational post‐marketing study
  di: Chenyang Shi, et al.
  Pubblicazione: (2024)
• Disrupted specialist outpatient services and alternative modes of service for patients with diabetes mellitus: A population‐based, retrospective cohort study in Hong Kong
  di: Yuk Kam Yau, et al.
  Pubblicazione: (2025)
• Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
  di: Satish K. Garg, et al.
  Pubblicazione: (2024)
• Sodium‐glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real‐world patients with type 2 diabetes
  di: Jingchuan Guo, et al.
  Pubblicazione: (2024)
• Work productivity, associated risk factors and costs on presenteeism and absenteeism in Chinese patients with young‐onset type‐2 diabetes in Hong Kong
  di: Juliana N. M. Lui, et al.
  Pubblicazione: (2025)